Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals Revenue

Syros Pharmaceuticals had revenue of $386.00K in the twelve months ending September 30, 2024, down -95.61% year-over-year. In the year 2023, Syros Pharmaceuticals had annual revenue of $9.94M, down -33.23%.

• Revenue (ttm): $386.00K
• Revenue Growth: -95.61%
• P/S Ratio: 20.91
• Revenue / Employee: $5,676
• Employees: 68
• Market Cap: 5.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.94M	-4.94M	-33.23%
Dec 31, 2022	14.88M	-8.61M	-36.65%
Dec 31, 2021	23.49M	8.40M	55.62%
Dec 31, 2020	15.09M	13.11M	661.50%
Dec 31, 2019	1.98M	-68.00K	-3.32%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.